The aim of this project is to study and characterize a novel form of RNA related neurological disorder due to dysfunction of a multi-protein complex called the human exosome. The role of the exosome consists of degradation and maturation of RNA. Mutations in the exosome subunit gene EXOSC3 were reported in patients with infantile-onset degeneration of the brainstem and cerebellum and muscle weakness due to spinal motor neuron dysfunction. We have recently identified mutations in EXOSC8, encoding another component of the human exosome, in infants with a similar severe neurological disease. In addition, these children also lose myelin in the brain and spinal cord, which normally coats and insulates nerves and serves to speed up signalling. The severe and isolated neurological symptoms in these children raise the possibility that the exosome is particularly important in neurons; however, there are still many open questions. Combining the data in human cells and zebrafish will enable us to better define the important genes and interacting partners of the exosome. By modifying exosome components or the some of the here identified interacting factors we may discover potential pathways to alter RNA degradation or processing in neurons, which can be further developed as a therapeutic approach in exosomal diseases or in other types of neurodegenerative diseases caused by abnormal RNA function.
Press the escape key to close the dialog menu.
Menu
- Menu
- Search
- News & Events
Tabs in this tab group open the tab panel widget in a dialog. Once a tab is interacted with, press the escape key to exit the dialog and return to the page content.
- Home
- Coronavirus Advice
- Coronavirus: latest update
- Covid-19 vaccine (BioNtec/Pfizer vaccine)
- Coronavirus: latest update
- Coronavirus: latest government advice on shielding
- Coronavirus: latest psychology update
- Coronavirus: psychology update for Mental Health Awareness Week
- Coronavirus: psychology update
- Coronavirus: latest psychology advice
- Coronavirus: psychology update
- Coronavirus: latest psychological advice for patients and families
- Coronavirus: latest psychological advice (FACE COVID)
- Coronavirus: Mental Health and Well-being
- Our Science Home Page
- Patient And Public
- What are mitochondria?
- About Our Clinic
- General information about mitochondrial disease
- Mitochondrial Reproductive Options
- Specific conditions
- Large-scale mitochondrial DNA deletions
- Neurogenic weakness, Ataxia, and Retinitis Pigmentosa (NARP)
- Multiple mitochondrial DNA deletions
- Mitochondrial Neuro-gastro-intestinal encephalopathy (MNGIE)
- Myoclonic Epilepsy and Ragged Red Fibres (MERRF 8344 A>G)
- Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) 3243 A>G mutation
- Leigh syndrome
- Mitochondrial DNA depletion syndrome (MDDS)
- Alpers’ syndrome
- Our Patient Days
- Mitonews
- Fundraising
- Clinical Professionals
- Clinical Guidelines
- Mitochondrial Patient Cohort
- Engagement
- Team members
- Principal Investigators
- Professor Zofia Chrzanowska-Lightowlers
- Dr Grainne Gorman
- Dr Laura Greaves
- Dr Gavin Hudson
- Professor Mary Herbert
- Professor Robert Lightowlers
- Professor Robert McFarland
- Dr Brendan Payne
- Prof Robert Taylor
- Prof Sir Doug Turnbull
- Dr Tom Nicholls
- Dr Amy Reeve
- Dr Oliver Russell
- Dr Amy Vincent
- Dr Sarah Pickett
- Dr Yi Shiau Ng
- Dr Charlotte Alston
- Post Doctoral Scientists
- Clinical Team Members
- Associated Researchers
- NHS Diagnostic Laboratory Team Members
- Post Graduate Students
- Administrative and Technical
- Principal Investigators
- WCMR Seminars
- Contact Us